Tempest Therapeutics, Inc.TPSTNASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank97
3Y CAGR+1070.6%
Year-over-Year Change
Year-over-year operating income growth rate
3Y CAGR
+1070.6%/yr
vs -78.0%/yr prior
Acceleration
+1148.6pp
Accelerating
Percentile
P97
Near historical high
vs 3Y Ago
1604.1x
Strong expansion
Streak
3 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | 54.85% |
| Q2 2025 | 27.16% |
| Q1 2025 | 21.43% |
| Q4 2024 | -31.91% |
| Q3 2024 | -10.11% |
| Q2 2024 | -20.17% |
| Q1 2024 | -6.12% |
| Q4 2023 | -13.99% |
| Q3 2023 | 11.75% |
| Q2 2023 | 1.46% |
| Q1 2023 | 15.14% |
| Q4 2022 | -1.86% |
| Q3 2022 | 0.03% |
| Q2 2022 | -7.51% |
| Q1 2022 | -11.22% |
| Q4 2021 | 5.14% |
| Q3 2021 | -14.02% |
| Q2 2021 | -32.34% |
| Q1 2021 | -18.60% |
| Q4 2020 | 20.45% |
| Q3 2020 | -3.74% |
| Q2 2020 | -21.73% |
| Q1 2020 | 66.46% |
| Q4 2019 | -9.19% |
| Q3 2019 | -15.66% |
| Q2 2019 | 4.66% |
| Q1 2019 | -16.76% |
| Q4 2018 | -56.15% |
| Q3 2018 | 26.05% |
| Q2 2018 | -4.25% |
| Q1 2018 | 10.76% |
| Q4 2017 | 9.67% |
| Q3 2017 | 40.98% |
| Q2 2017 | -21.67% |
| Q1 2017 | 41.44% |
| Q4 2016 | -17.95% |
| Q3 2016 | -3.96% |
| Q2 2016 | 14.92% |
| Q1 2016 | -5.92% |
| Q4 2015 | -13.89% |